Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred P Wirth

Showing results (231-240 of 272) with videos related to

Pageof 28
Sort By:
Neoplasia (New York, N.Y.)|July 2, 2008
Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping arrayMarieta I Toma, Marianne Grosser, Alexander Herr, et al.
International Journal of Molecular Sciences|May 31, 2020
Urinary MicroRNAs as Potential Markers for Non-Invasive Diagnosis of Bladder CancerKati Erdmann, Karsten Salomo, Anna Klimova, et al.
International Journal of Cancer|March 18, 2004
D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancerBernd Weigle, Andrea Kiessling, Reinhard Ebner, et al.
The Prostate|March 12, 2005
D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene familyAndrea Kiessling, Bernd Weigle, Susanne Fuessel, et al.
Urologic Oncology|September 21, 2017
Surgical resection of locally recurrent renal cell carcinoma after nephrectomy: Oncological outcome and predictors of survivalRoman Herout, Johannes Graff, Angelika Borkowetz, et al.
Genes, Chromosomes & Cancer|November 6, 2012
PARK2 and PACRG are commonly downregulated in clear-cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcomeMarieta I Toma, Daniela Wuttig, Sandy Kaiser, et al.
The Prostate|February 17, 2006
Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trialSusanne Fuessel, Axel Meye, Marc Schmitz, et al.
International Journal of Oncology|August 9, 2002
Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocolAxel Meye, Udo Bilkenroth, Uta Schmidt, et al.
BMC Cancer|November 25, 2017
An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatmentDoreen Huebner, Christiane Rieger, Ralf Bergmann, et al.
Biochemical and Biophysical Research Communications|August 18, 2004
D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostateBernd Weigle, Susanne Fuessel, Reinhard Ebner, et al.
Pageof 28

Showing results (231-240 of 272) with videos related to

Sort By:
Pageof 28
Neoplasia (New York, N.Y.)|July 2, 2008
Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping arrayMarieta I Toma, Marianne Grosser, Alexander Herr, et al.
International Journal of Molecular Sciences|May 31, 2020
Urinary MicroRNAs as Potential Markers for Non-Invasive Diagnosis of Bladder CancerKati Erdmann, Karsten Salomo, Anna Klimova, et al.
International Journal of Cancer|March 18, 2004
D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancerBernd Weigle, Andrea Kiessling, Reinhard Ebner, et al.
The Prostate|March 12, 2005
D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene familyAndrea Kiessling, Bernd Weigle, Susanne Fuessel, et al.
Urologic Oncology|September 21, 2017
Surgical resection of locally recurrent renal cell carcinoma after nephrectomy: Oncological outcome and predictors of survivalRoman Herout, Johannes Graff, Angelika Borkowetz, et al.
Genes, Chromosomes & Cancer|November 6, 2012
PARK2 and PACRG are commonly downregulated in clear-cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcomeMarieta I Toma, Daniela Wuttig, Sandy Kaiser, et al.
The Prostate|February 17, 2006
Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trialSusanne Fuessel, Axel Meye, Marc Schmitz, et al.
International Journal of Oncology|August 9, 2002
Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocolAxel Meye, Udo Bilkenroth, Uta Schmidt, et al.
BMC Cancer|November 25, 2017
An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatmentDoreen Huebner, Christiane Rieger, Ralf Bergmann, et al.
Biochemical and Biophysical Research Communications|August 18, 2004
D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostateBernd Weigle, Susanne Fuessel, Reinhard Ebner, et al.
Pageof 28